Pictet Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Pictet Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Hold	15,939	–	–	﹤0.01%	1713
2026 Q1	$221K	Hold	15,939	–	–	﹤0.01%	1890
2025 Q4	$259K	Hold	15,939	–	–	﹤0.01%	1785
2025 Q3	$238K	Buy	15,939 +3,794	+31%	+$46.2K	﹤0.01%	1783
2025 Q2	$141K	Sell	12,145 -5,600	-32%	-$50.9K	﹤0.01%	1893
2025 Q1	$132K	Sell	17,745 -9,192	-34%	-$70.6K	﹤0.01%	1880
2024 Q4	$161K	Sell	26,937 -1,274,846	-98%	-$7.03M	﹤0.01%	1898
2024 Q3	$6.51M	Sell	1,301,783 -380,222	-23%	-$1.66M	0.01%	754
2024 Q2	$6.09M	Sell	1,682,005 -1,818,959	-52%	-$5.77M	0.01%	748
2024 Q1	$10.7M	Buy	3,500,964 +78,608	+2%	+$304K	0.01%	637
2023 Q4	$16.8M	Buy	3,422,356 +379,652	+12%	+$1.73M	0.02%	522
2023 Q3	$16.6M	Buy	+3,042,704	New	+$20.1M	0.02%	506

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pictet Asset Management's ADPT Position: Q2 2026 in Review

Pictet Asset Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 15,939 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Pictet Asset Management first reported a position in ADPT in Q3 2023 and has held it in 12 quarters since. The position peaked at $16.8M in Q4 2023. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Pictet Asset Management held 15,939 shares of Adaptive Biotechnologies worth $342K as of Q2 2026.
Pictet Asset Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1713 holding.
Pictet Asset Management first reported a position in Adaptive Biotechnologies in Q3 2023 and has held it in 12 quarters since.
Pictet Asset Management's Adaptive Biotechnologies position peaked at $16.8M in Q4 2023.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.